The nature and management of metastatic melanoma after progression on <scp>BRAF</scp> inhibitors: Effects of extended <scp>BRAF</scp> inhibition - Concepedia

Concepedia

Publication | Closed Access

The nature and management of metastatic melanoma after progression on <scp>BRAF</scp> inhibitors: Effects of extended <scp>BRAF</scp> inhibition

72

Citations

30

References

2014

Year

Matthew Chan, Lauren E. Haydu, Alexander M. Menzies, Mary Azer, Oliver Klein, Megan Lyle, Arthur Clements, Alexander Guminski, Richard Kefford, Georgina V. Long

Abstract

Most BRAFi-treated patients progressed in existing extracranial sites, and 31% progressed in isolated sites. Compared with cessation, continued BRAFi TBP is associated with prolonged OS even after adjusting for potential prognostic factors at PD.

References

	Year	Citations

Page 1